Canopy Growth (CGC) Interest & Investment Income (2019 - 2025)

Canopy Growth (CGC) reported Interest & Investment Income of $4.4 million for Q4 2025, up 216.52% on a YoY basis from $1.4 million in Q4 2024, and up 206.3% sequentially from $1.4 million in Q3 2025.

Canopy Growth (CGC) Interest & Investment Income (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Interest & Investment Income data on file, last reported at $4.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income rose 216.52% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $8.0 million (up 23.86% YoY), and the FY2026 full-year result was $7.3 million, up 18.66% from the prior year.
  • Interest & Investment Income grew to $4.4 million in Q4 2025, from $1.4 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q1 2023 to a low of -$296842.8 in Q1 2022.
  • A 5-year average of $2.6 million and a median of $1.9 million in 2023 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income slumped 116.41% in 2022 and surged 2183.21% in 2023, its largest moves.
  • Tracing CGC's Interest & Investment Income over 5 years: stood at $1.2 million in 2021, then soared by 315.55% to $5.2 million in 2022, then plunged by 63.95% to $1.9 million in 2023, then slipped by 25.76% to $1.4 million in 2024, then soared by 216.52% to $4.4 million in 2025.
  • Business Quant data shows CGC's Interest & Investment Income at $4.4 million in Q4 2025, $1.4 million in Q3 2025, and $762850.1 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Canopy Growth 276.52 Mn 10.60 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.40 Mn
Sep 30, 2025 1.44 Mn
Jun 30, 2025 762,850.11
Dec 31, 2024 1.39 Mn
Sep 30, 2024 1.77 Mn
Jun 30, 2024 1.50 Mn
Mar 31, 2024 1.78 Mn
Dec 31, 2023 1.87 Mn
Sep 30, 2023 2.58 Mn
Jun 30, 2023 5.83 Mn
Mar 31, 2023 6.18 Mn
Dec 31, 2022 5.19 Mn
Sep 30, 2022 3.78 Mn
Jun 30, 2022 3.10 Mn
Mar 31, 2022 -296,842.75
Dec 31, 2021 1.25 Mn
Sep 30, 2021 2.19 Mn
Jun 30, 2021 2.15 Mn
Mar 31, 2021 1.81 Mn
Dec 31, 2020 5.61 Mn